Resverlogix Corp. (RVXCF)
RVXCF Stock Price Chart
Explore Resverlogix Corp. interactive price chart. Choose custom timeframes to analyze RVXCF price movements and trends.
RVXCF Company Profile
Discover essential business fundamentals and corporate details for Resverlogix Corp. (RVXCF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Feb 2009
Employees
19.00
Website
https://www.resverlogix.comCEO
Donald J. McCaffrey
Description
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
RVXCF Financial Timeline
Browse a chronological timeline of Resverlogix Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 14 Aug 2025
Earnings released on 14 May 2025
Earnings released on 28 Mar 2025
Earnings released on 12 Nov 2024
Earnings released on 14 Aug 2024
Earnings released on 14 May 2024
Earnings released on 26 Mar 2024
Earnings released on 30 Sept 2023
EPS came in at -$0.02 .
Earnings released on 30 Jun 2023
EPS came in at -$0.01 .
Earnings released on 31 Dec 2022
EPS came in at -$0.00 .
Earnings released on 10 Nov 2022
EPS came in at -$0.00 .
Earnings released on 30 Sept 2022
EPS came in at -$0.01 .
Earnings released on 31 Mar 2022
EPS came in at -$0.01 .
Earnings released on 31 Dec 2021
EPS came in at -$0.03 .
Earnings released on 30 Sept 2021
EPS came in at -$0.02 .
Earnings released on 30 Jun 2021
EPS came in at -$0.01 .
Earnings released on 31 Mar 2021
EPS came in at $0.00 .
Earnings released on 2 Oct 2020
EPS came in at -$0.02 .
Earnings released on 10 Sept 2020
EPS came in at $0.04 surpassing the estimated -$0.08 by +151.39%.
RVXCF Stock Performance
Access detailed RVXCF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.